Program DirectorHarvard Pilgrim Health Care Institute, United States
Disclosure information not submitted.
5C-02 - Quantitative Bias Analysis to Assess Impact of Outcome Misclassification in a Claims-based COVID-19 Vaccine Safety Study in the US
Tuesday, August 26, 20258:45 AM - 9:00 AM ET
5C-06 - Incidence Rates of Myocarditis/Pericarditis after Pfizer-BioNTech COVID-19 Vaccine in the United States: Interim Results From a Postapproval Safety Study, Primary Series Analysis
Tuesday, August 26, 20259:45 AM - 10:00 AM ET
